《本地樓市》宏安(01243.HK)以1.06億投得鴨(月利)洲南德大樓 統一舊樓業權
由宏安(01243.HK)收購的鴨(月利)洲南德大樓今日(19日)進行強拍,並以拍賣底價約1.06億元賣出,每平方呎樓面地價約7,171元,統一鴨(月利)洲舊樓業權。
南德大樓位於新市街37至39號,樓齡約51年,現為1幢樓高6層商住舊樓,地盤面積約1,594平方呎,現時規劃為「住宅(甲類)2」用途,若以重建地積比9倍發展,可建總樓面約14,346平方呎。
據資料顯示,宏安亦有收購鄰近的鴨(月利)洲大街17至23號及平瀾街5B至9號,若最終一併重建,地盤面積共約7,000平方呎,若以地積比9倍計,可重建樓面約6.3萬平方呎。(ca/s)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.